- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT02571452
Brief Behavioral Insomnia Treatment Study (BBTI)
Telephone-Facilitated Insomnia Treatment in Primary Care for OEF/OIF/OND Veterans
Tutkimuksen yleiskatsaus
Tila
Ehdot
Yksityiskohtainen kuvaus
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
California
-
San Francisco, California, Yhdysvallat, 94121
- San Francisco VA Medical Center, San Francisco, CA
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Veterans between the ages of 18-75 years.
- Meet DSM-5 Criteria for Insomnia Disorder.
- Able attend in-person appointments at the San Francisco VA Medical Center
The investigators will not exclude individuals who are taking insomnia or antidepressant medications, provided they have been stable on these medications for at least one month and still meet criteria for Insomnia Disorder as described above.
- Specifically, individuals receiving benzodiazepine or benzodiazepine receptor agonists, anticonvulsants, atypical antipsychotic medication, or non-SSRI antidepressant medications such as trazodone will not be excluded provided they meet the criteria described above.
The investigators will not exclude Veterans receiving any type of psychotherapy, provided they have received this treatment for at least three months and do not plan to discontinue this treatment during the BBTI trial.
- However, individual who need to start a new type of psychotherapy during the course of the treatment will be excluded, or they will need to wait three months in order to enroll in the trial.
- The investigators will not exclude individuals with TBI.
- The investigators will not exclude individuals with chronic pain.
- The investigators will not exclude individuals based on any other mental health condition, including posttraumatic stress disorder and depression.
Exclusion Criteria:
- Conditions that may be associated with comorbid insomnia, including a lifetime history of any psychiatric disorder with psychotic features or bipolar disorder, and alcohol or drug dependence within the past year.
- Individuals who meet criteria for alcohol or drug abuse will be asked to reduce alcohol to recommended limits during the course of the study and/or refrain from drug use in order to be included.
- Veterans with suicidal or homicidal ideation.
- Veterans who are pregnant, due to the biological impact of pregnancy on sleep.
- Veterans who work night or rotating shifts.
- Veterans with untreated moderate to severe sleep apnea (those receiving treatment will not be excluded from the study).
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Kokeellinen: Brief Behavioral Treatment for Insomnia
Participants will receive 4 weeks of Brief Behavioral Treatment for Insomnia (BBTI).
BBTI consists of two in-person sessions, with the two other sessions conducted via telephone.
BBTI emphasizes behavioral elements of insomnia treatment.
Treatment begins with sleep education and discussion of the biological rhythms that influence sleep cycles.
Next, a series of interventions are employed that are derived from sleep restriction and stimulus control techniques.
|
Participants will receive 4 weeks of Brief Behavioral Treatment for Insomnia (BBTI).
BBTI consists of two in-person sessions, with the two other sessions conducted via telephone.
BBTI emphasizes behavioral elements of insomnia treatment.
Treatment begins with sleep education and discussion of the biological rhythms that influence sleep cycles.
Next, a series of interventions are employed that are derived from sleep restriction and stimulus control techniques.
|
Active Comparator: Progressive Muscle Relaxation
Participants will receive 4 weeks of progressive muscle relaxation training (PMRT).
PMRT consists of two in-person and two phone sessions.
Treatment begins with training on muscle tensing and relaxing, and advances to progressively more efficient tensing-relaxing and passive relaxation exercises.
Sessions are employed that teach techniques and problem-solve barriers to the use of PMRT.
|
Participants will receive 4 weeks of progressive muscle relaxation training (PMRT).
PMRT consists of two in-person and two phone sessions.
Treatment begins with training on muscle tensing and relaxing, and advances to progressively more efficient tensing-relaxing and passive relaxation exercises.
Sessions are employed that teach techniques and problem-solve barriers to the use of PMRT.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Work and Social Adjustment Scale (WSAS)
Aikaikkuna: Change from Mid-treatment to Post-treatment (week 3 to week 5), with Baseline as a covariate
|
The WSAS assesses functioning at work, home, management, social leisure activities, private leisure activities, and relationships with others.
Scores range from 0-40, with higher scores meaning greater impairment.
The measure was administered at Baseline (week 0), Mid-treatment (week 3) & Post-treatment (week 5).
|
Change from Mid-treatment to Post-treatment (week 3 to week 5), with Baseline as a covariate
|
Work and Social Adjustment Scale (WSAS)
Aikaikkuna: Change from Post-treatment to Follow-up (after 6 months)--for treatment arm only
|
The WSAS assesses functioning at work, home, management, social leisure activities, private leisure activities, and relationships with others.
Scores range from 0-40, with higher scores meaning greater impairment.
The WSAS was administered at Follow-up (6 months Post-treatment) for participants receiving the experimental treatment only.
|
Change from Post-treatment to Follow-up (after 6 months)--for treatment arm only
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Insomnia Severity (ISI)
Aikaikkuna: Change from Mid-treatment to Post-treatment (week 3 to week 5), with Baseline as a covariate
|
The ISI is a specific index of perceived insomnia severity.
Areas assessed include problems with sleep onset, sleep maintenance, and early morning awakening; dissatisfaction with sleep; interference with daily functioning; impact on quality of life; and worry about sleep problems.
Scores range from 0-28, with higher scores meaning greater impairment.
The measure was administered at Baseline (week 0), Mid-treatment (week 3) & Post-treatment (week 5).
|
Change from Mid-treatment to Post-treatment (week 3 to week 5), with Baseline as a covariate
|
Insomnia Severity (ISI)
Aikaikkuna: Change from Post-treatment to Follow-up (after 6 months)--for treatment arm only
|
Insomnia Severity Index (ISI) is a specific index of perceived insomnia severity.
Areas assessed include problems with sleep onset, sleep maintenance, and early morning awakening; dissatisfaction with sleep; interference with daily functioning; impact on quality of life; and worry about sleep problems.
Scores range from 0-28, with higher scores meaning greater impairment.
The ISI was administered at Follow-up (6 months Post-treatment) for participants receiving the experimental treatment only.
|
Change from Post-treatment to Follow-up (after 6 months)--for treatment arm only
|
Yhteistyökumppanit ja tutkijat
Yhteistyökumppanit
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Ranney RM, Gloria R, Metzler TJ, Huggins J, Neylan TC, Maguen S. Brief behavioral treatment for insomnia decreases trauma-related nightmare frequency in veterans. J Clin Sleep Med. 2022 Jul 1;18(7):1831-1839. doi: 10.5664/jcsm.10002.
- Maguen S, Gloria R, Huggins J, Goldstein LA, Kanady JC, Straus LD, Metzler TJ, Lujan C, Neylan TC. Brief behavioral treatment for insomnia improves psychosocial functioning in veterans: results from a randomized controlled trial. Sleep. 2021 Mar 12;44(3):zsaa205. doi: 10.1093/sleep/zsaa205.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- D1539-I
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Yhdysvalloissa valmistettu ja sieltä viety tuote
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Unettomuushäiriö
-
Imagine InstituteRekrytointi
-
Linkoeping UniversityValmisWhiplash Associated DisorderRuotsi
-
University of OuluValmisSeasonal Affective Disorder (SAD)Suomi
-
Universitat Jaume IHospital de la RiberaEi vielä rekrytointiaBorderline Personality Disorder (BPD)Espanja
-
University of OldenburgProf. René Hurlemann; Jella Voelter, M.Sc.RekrytointiBorderline Personality Disorder (BPD)Saksa
-
University Hospital, Basel, SwitzerlandLeading House for the Latin American Region (Seed Money Grant SMG 1730)PeruutettuBorderline Personality Disorder (BPD)
-
GlaxoSmithKlineValmis
-
University Hospitals, LeicesterValmisWhiplash Associated DisorderYhdistynyt kuningaskunta
-
Kyunghee University Medical CenterUniversity of TsukubaValmis
-
NHS Greater Glasgow and ClydeTuntematonBorderline Personality Disorder (BPD) | Epäsosiaalinen persoonallisuushäiriö (ASPD)Yhdistynyt kuningaskunta
Kliiniset tutkimukset Brief Behavioral Treatment for Insomnia
-
The Miriam HospitalNational Heart, Lung, and Blood Institute (NHLBI)PeruutettuTupakan käyttö | Akuutti sepelvaltimo-oireyhtymäYhdysvallat
-
Florida International UniversityValmis
-
Nepalese Psychological AssociationTuntematonPosttraumaattinen stressihäiriö (PTSD)Nepal
-
Hospital de Clinicas de Porto AlegreTuntematonMasennus | Ahdistus | COVID | Ahdistusta | Mielenterveyden häiriö | Ärtyvä mielialaBrasilia
-
Oklahoma State UniversityUniversity of Oklahoma; University of Minnesota; Case Western Reserve University ja muut yhteistyökumppanitValmis
-
University of MiamiRekrytointi
-
Weill Medical College of Cornell UniversityUniversity of California, Los Angeles; University of Wisconsin, MilwaukeeValmisTouretten syndrooma | Touretten häiriö | Touretten häiriö | Gilles de la Touretten oireyhtymä | Touretten tauti | Touretten tauti | Tic-häiriö, yhdistetty laulu ja monimoottori | Useita moottori- ja äänihäiriöhäiriöitä, yhdistetty | Gilles de La Touretten tauti | Gilles de la Touretten syndrooma | Yhdistetty ääni-... ja muut ehdot
-
University of Wisconsin, MilwaukeeNational Institute of Mental Health (NIMH); University of UtahValmisTouretten syndrooma | Krooninen Tic-häiriöYhdysvallat
-
Baylor College of MedicineRekrytointi
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Johns Hopkins... ja muut yhteistyökumppanitEi vielä rekrytointiaHIV-ehkäisy | Epäterveellinen alkoholin käyttöVietnam